Overview
Williams syndrome (also known as Williams-Beuren syndrome) is a rare genetic disorder caused by a microdeletion of approximately 26-28 genes on chromosome 7q11.23, including the ELN (elastin) gene. This contiguous gene deletion occurs de novo in most cases and affects multiple body systems, producing a distinctive pattern of physical, cognitive, and behavioral features. The condition is typically recognizable in infancy or early childhood through a characteristic facial appearance often described as 'elfin-like,' featuring a broad forehead, short nose with a broad tip, full cheeks, wide mouth with full lips, and a small chin. The cardiovascular system is significantly affected, with supravalvular aortic stenosis (SVAS) being the hallmark cardiac finding, occurring in approximately 75% of individuals. Other vascular stenoses, including peripheral pulmonary artery stenosis and renal artery stenosis, may also occur and can lead to systemic hypertension. Hypercalcemia is common in infancy and may cause irritability and feeding difficulties. Individuals typically have mild to moderate intellectual disability, with a distinctive cognitive profile characterized by relative strengths in verbal abilities and social engagement, contrasted with significant weaknesses in visuospatial construction. A hallmark behavioral feature is an overly friendly, gregarious personality with a lack of social inhibition, often accompanied by anxiety and attention difficulties. Connective tissue abnormalities related to elastin deficiency can affect the skin, joints (hypermobility), and other organs. Endocrine issues including hypothyroidism and early puberty may occur. There is no cure for Williams syndrome, and management is multidisciplinary. Treatment focuses on regular cardiovascular monitoring and surgical intervention for significant stenoses, management of hypercalcemia through dietary modification, monitoring of blood pressure and renal function, and addressing endocrine abnormalities. Early intervention programs, speech therapy, occupational therapy, and specialized educational support are essential for optimizing developmental outcomes. Regular ophthalmologic and audiologic evaluations are also recommended. With appropriate medical surveillance and supportive care, many individuals with Williams syndrome can lead fulfilling lives, though most require some level of support throughout adulthood.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Infantile
Begins in infancy, roughly 1 month to 2 years old
FDA & Trial Timeline
4 eventsUniversity of Pennsylvania
Centre Hospitalier Universitaire, Amiens — NA
Sheba Medical Center — PHASE2
National Heart, Lung, and Blood Institute (NHLBI)
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Williams syndrome.
4 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Williams syndrome.
Community
No community posts yet. Be the first to share your experience with Williams syndrome.
Start the conversation →Latest news about Williams syndrome
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Williams syndrome
What is Williams syndrome?
Williams syndrome (also known as Williams-Beuren syndrome) is a rare genetic disorder caused by a microdeletion of approximately 26-28 genes on chromosome 7q11.23, including the ELN (elastin) gene. This contiguous gene deletion occurs de novo in most cases and affects multiple body systems, producing a distinctive pattern of physical, cognitive, and behavioral features. The condition is typically recognizable in infancy or early childhood through a characteristic facial appearance often described as 'elfin-like,' featuring a broad forehead, short nose with a broad tip, full cheeks, wide mouth
How is Williams syndrome inherited?
Williams syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Williams syndrome typically begin?
Typical onset of Williams syndrome is infantile. Age of onset can vary across affected individuals.
Are there clinical trials for Williams syndrome?
Yes — 4 recruiting clinical trials are currently listed for Williams syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Williams syndrome?
14 specialists and care centers treating Williams syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.